Levoketoconazole Patent Expiration
Levoketoconazole is used for treating Cushing's syndrome in patients with endogenous hypercortisolemia, when surgery is not an option or has not been curative. It was first introduced by Strongbridge Dublin Ltd
Levoketoconazole Patents
Given below is the list of patents protecting Levoketoconazole, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Recorlev | US11020393 | Methods of treating disease with levoketoconazole | Mar 02, 2040 | Strongbridge |
| Recorlev | US11278547 | Methods of treating disease with levoketoconazole | Mar 02, 2040 | Strongbridge |
| Recorlev | US11903940 | Methods of treating disease with levoketoconazole | Mar 02, 2040 | Strongbridge |
| Recorlev | US12377096 | Methods Of Treating Disease With Levoketoconazole | Mar 02, 2040 | Strongbridge |
| Recorlev | US9918984 | Methods and compositions for treating diabetes, metabolic syndrome and other conditions | May 03, 2028 | Strongbridge |
| Recorlev | US10098877 | Methods and compositions for treating diabetes, metabolic syndrome and other conditions |
Jan 10, 2026
(Expired) | Strongbridge |
| Recorlev | US10517868 | Methods and compositions for treating diabetes, metabolic syndrome and other conditions |
Jan 10, 2026
(Expired) | Strongbridge |
| Recorlev | US10835530 | Methods and compositions for treating diabetes, metabolic syndrome and other conditions |
Jan 10, 2026
(Expired) | Strongbridge |
| Recorlev | US11478471 | Methods and compositions for treating diabetes, metabolic syndrome and other conditions |
Jan 10, 2026
(Expired) | Strongbridge |
A patent's expiry date may change depending upon legal activities going on that patent. Critical
activities like
abandoning of a patent, term extension of a patent or amendment of its claims can increase or
decrease the life of a
patent hence affecting its expiry date and in turn affecting the generic launch date of that
drug. Tracking these
ongoing activities on a patent application helps to keep an eye on the latest developments in
the patent process of
the drug which can give an idea of how early a drug's generic could be available. The next
section provides a list
of recent legal activities on Levoketoconazole's patents.
Latest Legal Activities on Levoketoconazole's Patents
Given below is the list recent legal activities going on the following patents of Levoketoconazole.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Year, Large Entity | 12 Sep, 2025 | US11278547 |
| Payment of Maintenance Fee, 8th Yr, Small Entity | 10 Sep, 2025 | US9918984 |
| Notice of Final Determination -Eligible | 06 Jun, 2025 | US9918984 |
| FDA Final Eligibility Letter | 20 May, 2025 | US9918984 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 21 Nov, 2024 | US11020393 |
| Email Notification | 21 Aug, 2024 | US10835530 |
| Email Notification | 21 Aug, 2024 | US10098877 |
| Change in Power of Attorney (May Include Associate POA) | 21 Aug, 2024 | US10098877 |
| Email Notification | 21 Aug, 2024 | US10517868 |
| Change in Power of Attorney (May Include Associate POA) | 21 Aug, 2024 | US10517868 |
Levoketoconazole's Family Patents
